St. Luke’s University Health Turns to Auxira for Cardiology Support
Joanne Fulmer, St. Luke’s director of operations, says Auxira embeds a dedicated virtual Advanced Practice Provider directly into cardiology care teams
Read More
Madrigal Pharma Adds Another Genetic Medicine to Its Drug Combo Strategy in MASH
Madrigal Pharmaceuticals has licensed rights to an Arrowhead Pharmaceuticals small-interfering RNA therapy designed to address a particular genetic mutation associated with the fatty liver disease MASH. It’s Madrigal’s fourth business development deal of the past year and the company’s second one involving siRNA therapies. The post Madrigal Pharma Adds Another Genetic Medicine to Its Drug…
How I Learned To Trust AI as a Physical Therapist
If AI is going to be used in MSK care — or any area of healthcare — it needs clear, non-negotiable rules around it. The post How I Learned To Trust AI as a Physical Therapist appeared first on MedCity News.
Kidney Care Is Value‑Based Care’s Toughest Economic Test — and It’s Working
For years, the central question was whether value-based care could work at all. Today, evidence from kidney care moves us beyond that debate. The more urgent questions are who can scale these models effectively and whether the system will sustain what’s working long enough for it to endure. The post Kidney Care Is Value‑Based Care’s…
Healthcare Doesn’t Have an AI Problem — It Has a Readiness Problem
The path to scalable AI in healthcare will not be defined by a single breakthrough or technology. It will be shaped by the industry’s ability to address the foundational challenges that have existed for decades. The post Healthcare Doesn’t Have an AI Problem — It Has a Readiness Problem appeared first on MedCity News.
States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
LOS ANGELES — At Martin Luther King, Jr. Community Hospital, patients on gurneys line the hallways of the emergency department waiting for care, and overflow mental health patients are consigned to outdoor tents. The 152-bed hospital, which sits on a sprawling medical campus close to the predominantly Latino and Black neighborhood of Watts, is struggling…
What AI Can Do — And What It Can’t
The Business of Health with Chip Kahn May 5, 2026 Video https://www.youtube.
CRUSHing Lab Fraud: Three Myths that Derail Real Reform
Leeza Osipenko Ekaterina Cleary Julie Egginton By JULIE EGGINGTON, EKATERINA CLEARY & LEEZA OSIPENKO When CMS issued its Request for Information under the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative in February, it zeroed in on a long-festering problem: fraud, waste, and abuse in laboratory testing, especially in genetic and molecular diagnostics. The laboratory…
Does biosimilar entry reduce cost for patients?
Biosimilars aim to be lower cost options for biologic therapies after loss of exclusivity. A key question is whether these cost savings get passed through to patients via lower out-of-pocket costs. A paper by Dayer et al. (2026) aims to answer this question using 2011-2023 Merative MarketScan Commercial claims data. The authors observed: …significant patient…
Is the Atrium-WakeMed Merger Already Hitting a Wall?
A proposed merger between Atrium Health and WakeMed Health is facing an early delay, with county commissioners having postponed a key vote over transparency concerns. State officials are warning the deal could hurt competition and drive up healthcare costs in the Raleigh area. The post Is the Atrium-WakeMed Merger Already Hitting a Wall? appeared first…